1. TAK1 signaling is a potential therapeutic target for pathological angiogenesis
   Linxin Zhu et al, 2021, Angiogenesis CrossRef
2. NG25, a novel inhibitor of TAK1, suppresses KRAS-mutant colorectal cancer growth in vitro and in vivo
   Qizhao Ma et al, 2019, Apoptosis CrossRef